Expert on stem cell biology and regenerative medicine; developmental biology; ALS; Alzheimer’s disease; Frontotemporal Dementia; neurodegenerative diseases; induced pluripotent stem cells; cell reprogramming; disease modeling
USC Experts
Does air pollution increase women’s risk of dementia? Study finds high levels associated with brain shrinkage
The findings suggest that further tightening of air quality standards could potentially reduce the risk of dementia in older populations. Contact: Leigh Hopper, (310) 308-0405 or lhopper@usc.edu. Older women who live in locations with high levels of air pollution may have more Alzheimer’s-like brain shrinkage than women who live in places with cleaner air, according […]
USC study: protein in mitochondria appears to regulate health and longevity
Having greater amounts of the peptide humanin is closely correlated with longer lives and better health in both animals and humans, including lower risk for Alzheimer’s. Contact: Jenesse Miller, (213) 810-8554 or jenessem@usc.edu or Orli Belman, (310) 709-4156 or obelman@usc.edu A new study led by researchers at the USC Leonard Davis School of Gerontology is […]
USC study shows some combinations of statins and antihypertensives may reduce dementia risk
Researchers say the study is the first to investigate the association of different combinations of frequently used drugs and dementia risk in a large, representative sample of older Americans. Contact: Jenesse Miller, jenessem@usc.edu or 213-810-8554 Certain combinations of cardiovascular drugs may also reduce risk for Alzheimer’s disease, according to a new USC study of nearly […]
Researchers propose the “Alzheimer’s Disease Exposome” to understand environmental risks
USC and Duke researchers say the framework illustrates how environmental and genetic factors interact. Against a backdrop of disappointing Alzheimer’s disease clinical trial outcomes, two researchers are proposing a new approach for future study of the disease. Caleb Finch of the USC Leonard Davis School of Gerontology and Alexander Kulminski of the Social Science Research […]
Michael Rafii
Expert in Alzheimer’s disease, Alzheimer’s disease in Down syndrome, clinical trials
Cecily Jenkins
Expert in dementia and assessing age-related cognitive changes
John Ringman
Expert in neuropsychiatry; Alzheimer’s, dementia and other neurodegenerative diseases and cognitive disorders
Paul Aisen
Expert in Alzheimer’s disease research and director of USC Alzheimer’s Therapeutic Research Institute